Truist Financial
AXNX icon

Truist Financial’s Axonics, Inc. Common Stock AXNX Stock Holding History

Truist Financial’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,883
Closed -$304K – 2769
2023
Q4 		$304K Buy
4,883
+685
+16% +$38.3K ﹤0.01% 2298
2023
Q3 		$236K Sell
4,198
-1,353
-24% -$76.1K ﹤0.01% 2376
2023
Q2 		$280K Sell
5,551
-962
-15% -$51.2K ﹤0.01% 2284
2023
Q1 		$355K Sell
6,513
-3,781
-37% -$221K ﹤0.01% 2171
2022
Q4 		$644K Sell
10,294
-347
-3% -$23K ﹤0.01% 1786
2022
Q3 		$750K Buy
10,641
+4,575
+75% +$316K ﹤0.01% 1621
2022
Q2 		$344K Sell
6,066
-197
-3% -$10.8K ﹤0.01% 2131
2022
Q1 		$392K Buy
6,263
+994
+19% +$53.6K ﹤0.01% 2139
2021
Q4 		$295K Buy
+5,269
New +$322K ﹤0.01% 2372

Other funds holding AXNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS O'Connor
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Magnetar Financial
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Truist Financial's AXNX Position: Q1 2024 in Review

Truist Financial sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 4,883 shares — an estimated $304K sold.

Truist Financial first reported a position in AXNX in Q4 2021 and held it in 9 quarters. The position peaked at $750K in Q3 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

  • Truist Financial reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Truist Financial sold 4,883 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $304K.
  • Truist Financial first reported a position in Axonics, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
  • Truist Financial's Axonics, Inc. Common Stock position peaked at $750K in Q3 2022.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on Truist Financial's 13F filing for Q1 2024, filed 13 May 2024.